Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by StockNews.com
Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance NASDAQ:SRNE opened at $0.00 on Friday. Sorrento Therapeutics has a one year low of $0.00 and a […]
Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance NASDAQ:SRNE opened at $0.00 on Friday. Sorrento Therapeutics has a one year low of $0.00 and a […]
